(Breast & Ovarian) Lattice Biologics/Sunnybrook Research Institute Commence Study to Develop New Cancer Screening Methods Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present


Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Wednesday, April 06, 2016

(Breast & Ovarian) Lattice Biologics/Sunnybrook Research Institute Commence Study to Develop New Cancer Screening Methods

press release

Study Using Patient-Derived Cells Within Human Extracellular Matrix (ECM) to Replicate Heterogeneous Tumor Microenvironments Aims to Improve Breast and Ovarian Cancer Treatment by Decreasing Anti-cancer Drug Failure Rates on a Large-Scale

SCOTTSDALE, AZ--(Marketwired - March 30, 2016) -  Lattice Biologics Ltd. (TSX VENTURE: LBL)(OTCBB: BLVKF) ("Lattice Biologics" or the "Company") is pleased to announce it has entered into an Industry Sponsored Collaboration Agreement with Sunnybrook Research Institute ("SRI") in Toronto, Ontario titled, "Conditional Reprogramming of Epithelial Cells to Determine Mechanisms of Resistance and Drug Sensitivity" (the "Study"). The purpose of the Study is to develop new research methods, including the creation of new instruments to make cellular measurements, and the validation of methods to determine mechanisms of resistance and drug sensitivity. The successful identification of such new methods would lead to commercialization of high content screening (HCS) chemosensitivity testing for cancer patients.
"We are extremely pleased to be working with such a prestigious partner as Sunnybrook Research Institute to develop a personalized approach for cancer diagnostics," states Guy Cook, Chief Executive Officer of Lattice Biologics Ltd.
"Lattice Biologic's ECM technology is revolutionary in its unparalleled ability to accurately recreate complex tumor microenvironments because it allows us to grow biopsies from patients' own cancer tumors in the laboratory, subject the tumors to multiple anti-cancer agents, and observe the resulting behaviors all while sustaining natural conditions.
"This will provide a never-before-seen understanding of how individual patients' tumors respond to specific treatments, allowing physicians to prescribe anti-cancer treatments with new accuracy. This level of personalized medicine will change the entire cancer  treatment game......


Post a Comment

Your comments?